Cummings Keith Lamont's Form 4 filing
Pliant Therapeutics, Inc. (PLRX) · filed Jan 25, 2023
- Accession no.
- 0001140361-23-002783
- Filed
- Jan 25, 2023
- Trade date
- Jan 23, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cummings Keith LamontCIK 0001809204 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +12,500 | $2.08 | +$26,000 | 96,924 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseAcquired | +17,500 | $6.22 | +$108,850 | 114,424 | Direct | |
| Jan 23, 2023 | Common Stock | SSaleDisposed | −30,000 | $35.00 | −$1,050,000 | 84,424 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 133,597 | Direct | |
| Jan 23, 2023 | Common Stock | MOption exerciseDisposed | −17,500 | $0.00 | $0 | 18,198 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.